At this week’s COMET™ user meeting in Boston, Lunaphore customers came together to discuss their work, connect with other #spatialbiology researchers, and explore research breakthroughs supported by COMET. Thank you to all our attendees and speakers for an informative and interactive session. Let’s continue to COMET together, to push the boundaries of spatial biology research!
Lunaphore (a Bio-Techne brand)
Biotechnologieforschung
Tolochenaz, Vaud 22.324 Follower:innen
Accelerating Spatial Biology.
Info
Lunaphore Technologies S.A., a Bio-Techne brand, is a Swiss-based life sciences company founded in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies.
- Website
-
http://www.lunaphore.com
Externer Link zu Lunaphore (a Bio-Techne brand)
- Branche
- Biotechnologieforschung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Tolochenaz, Vaud
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2014
- Spezialgebiete
- Microfluidic technology, Immunohistochemistry, Cancer Research, Immuno-oncology research, Immunofluorescence und Multiplex
Orte
-
Primär
Route de Lully 5c
Tolochenaz, Vaud 1131, CH
Beschäftigte von Lunaphore (a Bio-Techne brand)
Updates
-
"Our histology facilities are incredible, but they are stretched thin. The COMET™ now allows our lab to perform any stain we want on the fly, while simultaneously creating a protocol that is easily transferrable to other members of the lab or community." Read the Front Line Genomics' interview with Dr. Rodrigo Romero to learn more about his #spatialbiology research: https://lnkd.in/eY8b8F5X
-
We started the Spatial Biology Europe Congress Oxford Global in Basel with a full-house presentation of Daniel Azorín, PhD from ETH Zürich. Did you miss the presentation? Make sure you visit the Lunaphore booth #3 and discuss with our experts how the new #multiomics solution can enhance your #spatialbiology projects.
-
We're thrilled to announce our strategic partnership with Discovery Life Sciences, which integrates our best-in-class COMET™ technology with Discovery's specialty lab services. Together, we're bringing innovative #spatialbiology solutions to clinical research and advancing spatial techniques in clinical trials. Read the press release to learn more: https://lnkd.in/eBVpJuU2
-
Dr. Monika Golinska's pioneering work at the Medical University of Lodz in collaboration with Cancer Research UK (CRUK) sheds light on the powerful role #spatialbiology can play in understanding complex diseases like #endometriosis. Leveraging our COMET™ technology, Dr. Golinska's research aims to transform the patient pathway and enhance treatment options for this overlooked condition, which affects 1 in 10 women. Read the latest European Association for Cancer Research (EACR) article to learn more: https://lnkd.in/eU6x3STN
-
The Spatial Biology Week™ is back! Open to everyone, our free virtual event will feature talks from 15 top experts across diverse research fields and applications. Whether you're interested in attending a single session or the full week, don’t miss this unique opportunity to gain valuable insights and expand your knowledge. Register now to secure your spot: https://lnkd.in/gehXvvfV
-
For this first Publication Spotlight, we come back to a recent tour de force study on spatial 3D #multiomics data integration and analysis led by Dr Sammy Ferri Borgogno and Dr. Jared K. Burks L. Burks from the University of Texas MD Anderson Cancer Center. 💡 Innovative twist Integrated spatially resolved omics data with different resolution into a single 3D space. 🚀 Study highlights - The authors developed an analytical pipeline that integrates 3D spatially resolved data generated from 2D datasets of three different spatial multiplex assays run on gynecological tumors. - The pipeline's core consists of a high resolution COMET™ image providing a precise profile of the tumors and used as a reference to map all other modalities into a single 3D space. - The resulting comprehensive macromolecule 3D map informs spatially on cell populations, metabolites, glycans, microbiome transcripts, human RNA and protein expression, all within a 3D tissue context. 👩🔬 Technical approach The authors sliced tumour blocks into 17 sections of 5µm: one every three sections was analysed by mass spectrometry imaging, spatial transcriptomics (Stereo-seq) and spatial proteomics (seqIF™ on COMET™). 🏥 Translational impact Identification of novel candidate biomarkers with specific spatial patterns to be validated and correlated with clinical outcome. 🔬 COMET™ contribution “The imaging produced from the seqIF™ is the cornerstone of the other imaging modalities, due to its ability to capture both morphological tissue patterns at high resolution, as well as molecular information about specific cell types present within the tissue.” Congratulations to all the authors for this innovative study and the impressive dataset generated! Want to know how COMET™ can advance your research and streamline your spatial analyses? Contact our scientists: [email protected]
-
“It’s an instrument that can be adapted to all our needs. It’s an antibody open-source technology, which is great because we have several antibodies that are not available on the market." Read this SelectScience® article to learn how Dr. Janusz F. Barraza, Fox Chase Cancer Center, is leveraging the COMET™ platform to drive cancer research: https://lnkd.in/ev95ZEse #spatialbiology
How spatial biology is driving tumor microenvironment research
selectscience.net
-
At this week's EMBO Workshop, we attended the inspiring presentation of Dr. Mauro Gwerder from the University of Bern. Dr. Gwerder showcased his research on outcome prediction in rectal cancer biopsies, highlighting the power of sequential immunofluorescence on our COMET™ platform. #spatialbiology
-
We are thrilled to announce our first Open Science Initiative awardee! At the Society for Neuro-Oncology Conference, Irina Palacín Aliana, PhD from Northwestern University, will present her novel glioblastoma research facilitated by COMET™ technology. Do you have COMET™ data ready to be published or presented? Apply now for support with travel and open-access publication fees: https://lnkd.in/eGHKtBJ3 #spatialbiology